Skip to main content
  • Original article
  • Open access
  • Published:

The role of biofeedback in the rehabilitation of veno-occlusive erectile dysfunction

Abstract

Background

Pelviperineal muscles play a role in erection through the enhancement of blood flow to the penis. Hence, the reinforcement of the power of such muscles through noninvasive visual pressure biofeedback rehabilitation may be helpful in erectile function improvement.

Aim

The aim of this study was to assess the value of pelviperineal muscles’ visual pressure biofeedback rehabilitation in the treatment of organic veno-occlusive erectile dysfunction (ED).

Materials and methods

This study included 30 patients with veno-occlusive ED. Exclusion criteria were neurological, psychological, endocrinal, and arterial insufficiency ED. Also, patients with malignancies, chronic renal failure, liver cell failure, urological congenital abnormalities, pelvic surgery, pelvic radiation, or trauma and patients on medications known to cause ED were excluded. All patients performed visual pressure biofeedback strengthening of the pelviperineal muscles three times weekly for 3 months. In addition to clinical and laboratory evaluations, patients were assessed by a self-administered questionnaire, a neurophysiological examination, a pharmacopenile duplex ultrasound, and the anal hold pressure.

Results

According to the self-administered questionnaire, 16/30 patients (53.3%) showed either partial or complete improvement (11 and five patients, respectively). On comparing prerehabilitation and postrehabilitation results of the pharmacopenile duplex ultrasound, 18/30 patients (60%) showed either partial or complete improvement (13 and five patients, respectively). The anal hold pressure improved from 120.7 to 189.9 after biofeedback rehabilitation.

Conclusion

Pelviperineal muscles’ visual pressure biofeedback rehabilitation is effective, inexpensive, noninvasive, safe, and easily applicable in the treatment of venogenic ED and does not have as much side effects as medication.

References

  1. Billups KL, Bank AJ, Padma-Nathan H, Katz SD, Williams RA. Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int J Impot Res 2008; 20:236–242.

    CAS  PubMed  Google Scholar 

  2. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003; 89:251–253.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Meldrum DR, Gambone JC, Morris MA, Meldrum DA, Esposito K, Ignarro LJ. The link between erectile and cardiovascular health: the canary in the coal mine. Am J Cardiol 2011; 108:599–606.

    PubMed  Google Scholar 

  4. Bird IM. Endothelial nitric oxide synthase activation and nitric oxide function: new light through old windows. J Endocrinol 2011; 210:239–241.

    CAS  PubMed  Google Scholar 

  5. Giuliano F. Neurophysiology of erection and ejaculation. J Sex Med 2011; 8:310–5.

    PubMed  Google Scholar 

  6. Han WR, Chuang CY, Li PC, Chen KK, Young ST. Intracavernosal pressure characteristics analyzed by power spectral density for identifying the phase of penile erection. Int J Impot Res 2009; 21:336–42.

    PubMed  Google Scholar 

  7. Dorey G. Pelvic floor exercises as a treatment for men with erectile dysfunction. Nurs Times 2004; 100:65–67.

    PubMed  Google Scholar 

  8. Caretta N, Foresta C. Clinical diagnostic approach to erectile dysfunction. Minerva Ginecol 2007; 59:51–61.

    CAS  PubMed  Google Scholar 

  9. Broderick GA, Lue TF. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA editors.. Evaluation and non surgical management of erectile dysfunction and priapism. Vol. 2, section 8, chapter 46. Campbell’s urology. 8th ed.. Pennsylvania, USA: Saunders, an imprint of Elsevier; 2002. 1619–1671.

    Google Scholar 

  10. Burnett AL. Erectile dysfunction. J Urol 2006; 175:S25–S31.

    PubMed  Google Scholar 

  11. Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ Urologic Diseases in America Project. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med 2006; 166:207–212.

    Google Scholar 

  12. Kandeel FR, Koussa VK, Swerdloff RS. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr Rev 2001; 22:342–388.

    CAS  PubMed  Google Scholar 

  13. Kloner RA. Erectile dysfunction and cardiovascular risk factors. Urol Clin North Am 2005; 32:397–402.

    PubMed  Google Scholar 

  14. Valles Antuña C, Fernández Gómez JM, Escaf S, Fernández-González F. Neurogenic etiology in patients with erectile dysfunction. Arch Esp Urol 2008; 61:403–411.

    PubMed  Google Scholar 

  15. Goyal A, Singh P, Ahuja A. Prevalence and severity of erectile dysfunction as assessed by IIEF-5 in North Indian type 2 diabetic males and its correlation with variables. J Clin Diagn Res 2013; 7:2936–2938.

    PubMed  PubMed Central  Google Scholar 

  16. Mulhall JP, Damaser MS. Development of a mathematical model for the prediction of the area of venous leak. Int J Impot Res 2001; 13:236–239.

    CAS  PubMed  Google Scholar 

  17. Gareri P, Castagna A, Francomano D, Cerminara G, De Fazio P. Erectile dysfunction in the elderly: an old widespread issue with novel treatment perspectives. Int J Endocrinol 2014; 2014:878670.

    PubMed  PubMed Central  Google Scholar 

  18. Stein MJ, Lin H, Wang R. New advances in erectile technology. Ther Adv Urol 2014; 6:15–24.

    PubMed  PubMed Central  Google Scholar 

  19. Van Kampen M, De Weerdt W, Claes H, Feys H, De Maeyer M, Van Poppel H. Treatment of erectile dysfunction by perineal exercise, electromyographic biofeedback, and electrical stimulation. Phys Ther 2003; 83:536–543.

    PubMed  Google Scholar 

  20. Madeo B, Bettica P, Milleri S, Balestrieri A, Granata AR, Carani C, Rochira V. The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study. J Sex Med 2008; 5:2431–2441.

    CAS  PubMed  Google Scholar 

  21. Yang C, Tang K, Wang B. Clinical value of serum 5-HT level in diagnosis and treatment of premature ejaculation. Urol Int 2013; 90:214–218.

    CAS  PubMed  Google Scholar 

  22. Elhanbly S, Elkholy A. Nocturnal penile erections: the role of RigiScan in the diagnosis of vascular erectile dysfunction. J Sex Med 2012; 9: 3219–3226.

    PubMed  Google Scholar 

  23. Amarenco G, Sheikh Ismaël S, Verollet D, Le Breton F, Lacroix P, Fahed M. Clinical and electrophysiological study of sensory penile alterations. A prospective study of 44 cases. Prog Urol 2013; 23:946–950.

    CAS  PubMed  Google Scholar 

  24. Hamdan FB, Al-Matubsi HY. Assessment of erectile dysfunction in diabetic patients. Int J Androl 2009; 32:176–185.

    PubMed  Google Scholar 

  25. Xia JD, Han YF, Zhou LH, Xu ZP, Chen Y, Dai YT. Sympathetic skin response in patients with primary premature ejaculation. Int J Impot Res 2014; 26:31–34.

    PubMed  Google Scholar 

  26. Valles-Antuña C, Fernandez-Gomez J, Escaf S, Fernandez-Gonzalez F. Sympathetic skin response in patients with erectile dysfunction. BJU Int 2009; 104:1709–1712.

    PubMed  Google Scholar 

  27. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11:319–326.

    CAS  PubMed  Google Scholar 

  28. Dorey G, Speakman M, Feneley R, Swinkels A, Dunn C, Ewings P. Randomised controlled trial of pelvic floor muscle exercises and manometric biofeedback for erectile dysfunction. Br J Gen Pract 2004; 54:819–825.

    PubMed  PubMed Central  Google Scholar 

  29. Sun X, Wang R, Zhang L, Li D, Li Y. Efficacy of pelvic floor muscle training for the treatment of fecal incontinence after Soave procedure for Hirschsprung disease. Eur J Pediatr Surg 2012; 22:300–304.

    PubMed  Google Scholar 

  30. Golijanin D, Singer E, Davis R, Bhatt S, Seftel A, Dogra V. Doppler evaluation of erectile dysfunction –part 2. Int J Impot Res 2007; 19:43–48.

    CAS  PubMed  Google Scholar 

  31. Rubio-Aurioles E, Kim ED, Rosen RC, Porst H, Burns P, Zeigler H, Wong DG. Impact on erectile function and sexual quality of life of couples: a double-blind, randomized, placebo-controlled trial of tadalafil taken once daily. J Sex Med 2009; 6:1314–1323.

    CAS  PubMed  Google Scholar 

  32. Yang M, Ni X, Sontag A, Litman HJ, Rosen RC. Nonresponders, partial responders, and complete responders to PDE5 inhibitors therapy according to IIEF criteria: validation of an anchor-based treatment responder classification. J Sex Med 2013; 10:3029–3037.

    CAS  PubMed  Google Scholar 

  33. Gorgel SN, Gorgel A, Sefik E. Sexual function in male patients with metabolic syndrome and effective parameters on erectile dysfunction. Int Braz J Urol 2014; 40:56–61.

    PubMed  Google Scholar 

  34. Zhang K, Xu B, Liu D, Wang X, Zhu J, Deng C, et al. Sildenafil improves erectile hardness in Chinese men with erectile dysfunction: a real-life study analyzed on age stratification. Urology 2014; 83:831–836.

    PubMed  Google Scholar 

  35. MacDonagh RP, Porter T, Pontin D, Ewings P. The ED-EQoL: the development of a new quality of life measure for patients with erectile dysfunction. Qual Life Res 2004; 13:361–368.

    CAS  PubMed  Google Scholar 

  36. Sommer F, Axel R, Bondarenko B, Caspers H, Esders K, Bartsch G. A conservative treatment option of curing venous leakage in impotent men. Eur Urol Suppl 2002; 1:153.

    Google Scholar 

  37. Hsiao W, Shrewsberry AB, Moses KA, Johnson TV, Cai AW, Stuhldreher P, et al. Exercise is associated with better erectile function in men under 40 as evaluated by the International Index of Erectile Function. J Sex Med 2012; 9:524–530.

    PubMed  Google Scholar 

  38. Hellstrom WJ, Montague DK, Moncada I, Carson C, Minhas S, Faria G, Krishnamurti S. Implants, mechanical devices, and vascular surgery for erectile dysfunction. J Sex Med 2010; 7:501–523.

    PubMed  Google Scholar 

  39. Blute M, Hakimian P, Kashanian J, Shteynshluyger A, Lee M, Shabsigh R. Erectile dysfunction and testosterone deficiency. Front Horm Res 2009; 37:108–122.

    CAS  PubMed  Google Scholar 

  40. Jakubczyk T. Intracavernosal injections in the diagnosis and treatment of PDE-5 resistant erectile dysfunction. Cent European J Urol 2013; 66:215–216.

    PubMed  PubMed Central  Google Scholar 

  41. Frank DL, Khorshid L, Kiffer JF, Moravec CS, McKee MG Biofeedback in medicine: who, when, why and how?. Ment Health Fam Med 2010; 7:85–91.

    PubMed  PubMed Central  Google Scholar 

  42. Dorey G, Speakman MJ, Feneley RC, Swinkels A, Dunn CD. Pelvic floor exercises for erectile dysfunction. BJU Int 2005; 96:595–597.

    PubMed  Google Scholar 

  43. Virag R, Paul JF. New classification of anomalous venous drainage using caverno-computed tomography in men with erectile dysfunction. J Sex Med 2011; 8:1439–1444.

    PubMed  Google Scholar 

  44. Chung E, Yan H, De Young L, Brock GB. Penile Doppler sonographic and clinical characteristics in Peyronie’s disease and/or erectile dysfunction: an analysis of 1500 men with male sexual dysfunction. BJU Int 2012; 110:1201–1205.

    PubMed  Google Scholar 

  45. Prota C, Gomes CM, Ribeiro LH, de Bessa J Jr, Nakano E, Dall’Oglio M, et al. Early postoperative pelvic-floor biofeedback improves erectile function in men undergoing radical prostatectomy: a prospective, randomized, controlled trial. Int J Impot Res 2012; 24:174–178.

    CAS  PubMed  Google Scholar 

  46. Sighinolfi MC, Rivalta M, Mofferdin A, Micali S, De Stefani S, Bianchi G. Potential effectiveness of pelvic floor rehabilitation treatment for postradical prostatectomy incontinence, climacturia, and erectile dysfunction: a case series. J Sex Med 2009; 6:3496–3499.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mahmoud M. Fathalla MD.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Al-Helow, M.R., Abdul-Hady, H., Fathalla, M.M. et al. The role of biofeedback in the rehabilitation of veno-occlusive erectile dysfunction. Egypt Rheumatol Rehabil 41, 179–186 (2014). https://doi.org/10.4103/1110-161X.147362

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1110-161X.147362

Keywords